Platinum-based chemotherapy has been proven to be an effective treatment for BRCA1 and BRCA2 mutated breast [31,32] and ovarian cancers [33] as these compounds generate DNA cross-links that cannot be easily resolved with an impaired homologous recombination (HR). The gene discussed is BRCA2; the disease is ovarian carcinoma.